US EditionPublished • loading... • Updated
Moderna Gets a Scientific Green Light in Europe for Her New Covid-19 Vaccine: "the over 65s Are Still Affected by Severe Forms"
Summary by La Libre
3 Articles
3 Articles
In 2020, Moderna had marketed one of the first two vaccines against Covid-19 using innovative messenger RNA technology (Spikevax), against Pfizer-BioNTech.
In 2020, Moderna had marketed one of the first two vaccines against Covid-19 using messenger RNA technology The US biotechnology company Moderna announced Tuesday
·France
Read Full Article
The European Medicines Agency recommends the authorisation of Moderna's new generation mNexspike vaccine for people 12 years of age and older. ...
·Brussels, Belgium
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left0Leaning Right0Center3Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
